『EyePod』のカバーアート

EyePod

EyePod

著者： Ophthalmology Times
無料で聴く

このコンテンツについて

 Hosted by the award-winning editorial staff of Ophthalmology Times®, EyePod podcasts feature the latest updates and resources most relevant to professionals across the eyecare industry. 生物科学 科学
エピソード
  • 3 Things You Should Know About Interventional Glaucoma Comanagement

    3 Things You Should Know About Interventional Glaucoma Comanagement
    2025/06/04
    Glaucoma is a leading cause of irreversible blindness and affects approximately 80 million people globally, with projections to exceed .111 million by 2040. We know that the elevated intraocular pressure is the key modifiable risk factor which is why reducing intraocular pressure is central to treatment strategies.

    In this podcast, expert faculty from the featured symposium at the 2025 EnVision Summit share insights about interventional glaucoma co-management.

    Those faculty include ophthalmologists Rachel Simpson from Moran Eye Center in

    Salt Lake City, UT; James Murphy from Connecticut Eye Physicians in New Haven, CT; Mary Qiu from the Cleveland Clinic’s Cole Eye Institute in Cleveland, Ohio; and optometrist Jessica Steen from the Nova Southeastern University College of Optometry in Fort Lauderdale, FL.
    続きを読む 一部表示
    32 分
  • 3 Things You Should Know About Early Treatment Intervention for TED

    3 Things You Should Know About Early Treatment Intervention for TED
    2025/05/30
    Thyroid eye disease (TED), a rare autoimmune condition, can be sight-threatening, debilitating, and disfiguring, severely impacting patients’ quality of life and daily functioning. Traditional management approaches for TED have centered on immunomodulatory therapy and surgical interventions. In January 2020, the US Food and Drug Administration (FDA) approved teprotumumab, the first therapy specifically indicated for TED. As treatment options evolve, there is an increasing need for a patient-centered, multidisciplinary approach, which is essential to address individual patient needs throughout the disease course.

    This PER On Air Ophthalmology Times podcast provides an in-depth review of some of the key highlights from a satellite symposium that took place at the Envision Summit 2025 meeting in February 2025. This unique and engaging activity focuses on the practical aspects of managing patients with thyroid eye disease, putting recent clinical trial data into clinical context. The program is designed for those who did not attend the live meeting and to help reinforce learnings for those who did.
    続きを読む 一部表示
    16 分
  • Patient-Centered Treatment Strategies in the Management of nAMD and DME

    Patient-Centered Treatment Strategies in the Management of nAMD and DME
    2025/05/30
    Recently approved anti-VEGF agents that target additional pathways and offer innovative delivery methods with longer-lasting effects may provide advantages over older anti-VEGF agents in managing patients with neovascular age-related macular degeneration (nAMD) and diabetic macular edema (DME). In this podcast, expert faculty discuss the roles of ophthalmologists and optometrists in managing nAMD and DME in an evolving treatment landscape, from screening and diagnosis to referral and ongoing patient care.
    続きを読む 一部表示
    14 分

EyePodに寄せられたリスナーの声

カスタマーレビュー：以下のタブを選択することで、他のサイトのレビューをご覧になれます。

Audible.co.jp

Amazon.co.jp
レビューはまだありません。